Congenital Heart Disease Research Program (CHDRP)
U.S. Department of Defense – Congressionally Directed Medical Research Programs (CDMRP)
The Congenital Heart Disease Research Program (CHDRP) under the Congressionally Directed Medical Research Programs (CDMRP) supports transformational biomedical research aimed at improving the prevention, diagnosis, treatment, and lifelong management of congenital heart defects (CHDs). As the most common birth defect worldwide, congenital heart disease affects thousands of children and adults in military families who may require specialized care across the lifespan. CHDRP promotes scientific innovation that strengthens clinical outcomes, enhances survivorship, and elevates the quality of life for affected individuals and their caregivers.
Research priorities include early detection technologies, advanced fetal or neonatal imaging, minimally invasive surgical methods, regenerative repair strategies, molecular mechanisms of cardiac development, genetic or epigenetic risk profiling, and biomarker discovery for disease progression. The program also encourages work that improves long-term outcomes following cardiac surgery, including neurodevelopmental monitoring, cardiac rehabilitation, precision-medicine approaches, device optimization, and survivorship analytics. Projects leveraging AI-enabled image processing, pediatric heart-modeling, digital monitoring platforms, or telehealth care-coordination systems are especially responsive.
A defining element of CHDRP is its emphasis on lifelong care and care transitions, reflecting military family realities in which dependents may move frequently, face variable access to specialized pediatric and adult cardiology services, and encounter elevated stress conditions. Studies exploring access disparities, remote management tools, wearable monitoring, family-centered care pathways, and readiness for emergency cardiac intervention are highly relevant.
Eligibility is broad, welcoming proposals from universities, academic medical centers, nonprofit research organizations, federally funded laboratories, large research corporations, and emerging biotechnology or digital-health companies. Small businesses developing pediatric cardiac devices, AI-assisted clinical-decision software, surgical innovation platforms, or remote biomonitoring solutions may be particularly competitive. Clinical research may involve prospective cohort studies, adaptive trial designs, device feasibility assessments, rehabilitation or developmental tracking, and technology-enabled monitoring.
Applications are evaluated through rigorous scientific peer review and programmatic review focused on innovation, feasibility, impact on congenital heart disease, military relevance, clinical utility, and long-term survivorship benefit. Successful submissions clearly connect mechanistic discovery or translational innovation to meaningful improvements in pediatric cardiac outcomes and lifelong health trajectories.
ScienceDocs Proposal Support
ScienceDocs provides expert assistance for CDMRP Congenital Heart Disease Research Program proposals, including research strategy development, clinical study design, pediatric monitoring platforms, survivorship analytics, and narrative production. To request professional support for a CHDRP submission, visit: